Oncopharmpod
Updates from December 2020
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:19:36
- More information
Informações:
Synopsis
The 1st episode of 2021 covers 5 FDA updates from December 2020 -Pralsetinib for RET-mutated medullary thyroid cancer -The new HER2-targeting margetuximab -Selinexor and the Boston study -Relugolix, an oral GnRH antagonist -Adjuvant osimertinib approved (ADAURA)
